Global Leadless Cardiac Pacemakers Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Leadless Cardiac Pacemakers Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Single-Chamber Ventricular
- 1.3.3 Single-Chamber Atrial
- 1.3.4 Atrioventricular (AV) Synchronous
- 1.3.5 Dual-Chamber
- 1.4 Market Analysis by Fixation Mechanism
- 1.4.1 Overview: Global Leadless Cardiac Pacemakers Consumption Value by Fixation Mechanism: 2021 Versus 2025 Versus 2032
- 1.4.2 Flexible Tines/Anchors
- 1.4.3 Screw-In Mechanism
- 1.5 Market Analysis by Manageability
- 1.5.1 Overview: Global Leadless Cardiac Pacemakers Consumption Value by Manageability: 2021 Versus 2025 Versus 2032
- 1.5.2 Retrievable/Upgradable
- 1.5.3 Permanent Implant
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Leadless Cardiac Pacemakers Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Adults
- 1.6.3 Children
- 1.7 Global Leadless Cardiac Pacemakers Market Size & Forecast
- 1.7.1 Global Leadless Cardiac Pacemakers Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Leadless Cardiac Pacemakers Sales Quantity (2021-2032)
- 1.7.3 Global Leadless Cardiac Pacemakers Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Medtronic
- 2.1.1 Medtronic Details
- 2.1.2 Medtronic Major Business
- 2.1.3 Medtronic Leadless Cardiac Pacemakers Product and Services
- 2.1.4 Medtronic Leadless Cardiac Pacemakers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Medtronic Recent Developments/Updates
- 2.2 Abbott
- 2.2.1 Abbott Details
- 2.2.2 Abbott Major Business
- 2.2.3 Abbott Leadless Cardiac Pacemakers Product and Services
- 2.2.4 Abbott Leadless Cardiac Pacemakers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Abbott Recent Developments/Updates
- 2.3 Biotronik
- 2.3.1 Biotronik Details
- 2.3.2 Biotronik Major Business
- 2.3.3 Biotronik Leadless Cardiac Pacemakers Product and Services
- 2.3.4 Biotronik Leadless Cardiac Pacemakers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Biotronik Recent Developments/Updates
- 2.4 Boston Scientific
- 2.4.1 Boston Scientific Details
- 2.4.2 Boston Scientific Major Business
- 2.4.3 Boston Scientific Leadless Cardiac Pacemakers Product and Services
- 2.4.4 Boston Scientific Leadless Cardiac Pacemakers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Boston Scientific Recent Developments/Updates
- 2.5 MicroPort
- 2.5.1 MicroPort Details
- 2.5.2 MicroPort Major Business
- 2.5.3 MicroPort Leadless Cardiac Pacemakers Product and Services
- 2.5.4 MicroPort Leadless Cardiac Pacemakers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 MicroPort Recent Developments/Updates
- 2.6 EBR Systems
- 2.6.1 EBR Systems Details
- 2.6.2 EBR Systems Major Business
- 2.6.3 EBR Systems Leadless Cardiac Pacemakers Product and Services
- 2.6.4 EBR Systems Leadless Cardiac Pacemakers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 EBR Systems Recent Developments/Updates
3 Competitive Environment: Leadless Cardiac Pacemakers by Manufacturer
- 3.1 Global Leadless Cardiac Pacemakers Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Leadless Cardiac Pacemakers Revenue by Manufacturer (2021-2026)
- 3.3 Global Leadless Cardiac Pacemakers Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Leadless Cardiac Pacemakers by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Leadless Cardiac Pacemakers Manufacturer Market Share in 2025
- 3.4.3 Top 6 Leadless Cardiac Pacemakers Manufacturer Market Share in 2025
- 3.5 Leadless Cardiac Pacemakers Market: Overall Company Footprint Analysis
- 3.5.1 Leadless Cardiac Pacemakers Market: Region Footprint
- 3.5.2 Leadless Cardiac Pacemakers Market: Company Product Type Footprint
- 3.5.3 Leadless Cardiac Pacemakers Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Leadless Cardiac Pacemakers Market Size by Region
- 4.1.1 Global Leadless Cardiac Pacemakers Sales Quantity by Region (2021-2032)
- 4.1.2 Global Leadless Cardiac Pacemakers Consumption Value by Region (2021-2032)
- 4.1.3 Global Leadless Cardiac Pacemakers Average Price by Region (2021-2032)
- 4.2 North America Leadless Cardiac Pacemakers Consumption Value (2021-2032)
- 4.3 Europe Leadless Cardiac Pacemakers Consumption Value (2021-2032)
- 4.4 Asia-Pacific Leadless Cardiac Pacemakers Consumption Value (2021-2032)
- 4.5 South America Leadless Cardiac Pacemakers Consumption Value (2021-2032)
- 4.6 Middle East & Africa Leadless Cardiac Pacemakers Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Leadless Cardiac Pacemakers Sales Quantity by Type (2021-2032)
- 5.2 Global Leadless Cardiac Pacemakers Consumption Value by Type (2021-2032)
- 5.3 Global Leadless Cardiac Pacemakers Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Leadless Cardiac Pacemakers Sales Quantity by Application (2021-2032)
- 6.2 Global Leadless Cardiac Pacemakers Consumption Value by Application (2021-2032)
- 6.3 Global Leadless Cardiac Pacemakers Average Price by Application (2021-2032)
7 North America
- 7.1 North America Leadless Cardiac Pacemakers Sales Quantity by Type (2021-2032)
- 7.2 North America Leadless Cardiac Pacemakers Sales Quantity by Application (2021-2032)
- 7.3 North America Leadless Cardiac Pacemakers Market Size by Country
- 7.3.1 North America Leadless Cardiac Pacemakers Sales Quantity by Country (2021-2032)
- 7.3.2 North America Leadless Cardiac Pacemakers Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Leadless Cardiac Pacemakers Sales Quantity by Type (2021-2032)
- 8.2 Europe Leadless Cardiac Pacemakers Sales Quantity by Application (2021-2032)
- 8.3 Europe Leadless Cardiac Pacemakers Market Size by Country
- 8.3.1 Europe Leadless Cardiac Pacemakers Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Leadless Cardiac Pacemakers Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Leadless Cardiac Pacemakers Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Leadless Cardiac Pacemakers Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Leadless Cardiac Pacemakers Market Size by Region
- 9.3.1 Asia-Pacific Leadless Cardiac Pacemakers Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Leadless Cardiac Pacemakers Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Leadless Cardiac Pacemakers Sales Quantity by Type (2021-2032)
- 10.2 South America Leadless Cardiac Pacemakers Sales Quantity by Application (2021-2032)
- 10.3 South America Leadless Cardiac Pacemakers Market Size by Country
- 10.3.1 South America Leadless Cardiac Pacemakers Sales Quantity by Country (2021-2032)
- 10.3.2 South America Leadless Cardiac Pacemakers Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Leadless Cardiac Pacemakers Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Leadless Cardiac Pacemakers Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Leadless Cardiac Pacemakers Market Size by Country
- 11.3.1 Middle East & Africa Leadless Cardiac Pacemakers Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Leadless Cardiac Pacemakers Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Leadless Cardiac Pacemakers Market Drivers
- 12.2 Leadless Cardiac Pacemakers Market Restraints
- 12.3 Leadless Cardiac Pacemakers Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Leadless Cardiac Pacemakers and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Leadless Cardiac Pacemakers
- 13.3 Leadless Cardiac Pacemakers Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Leadless Cardiac Pacemakers Typical Distributors
- 14.3 Leadless Cardiac Pacemakers Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Leadless Cardiac Pacemakers market size was valued at US$ 990 million in 2025 and is forecast to a readjusted size of US$ 1473 million by 2032 with a CAGR of 5.9% during review period.
In 2025, global production of leadless cardiac pacemakers reached 102,000 units, with an estimated average selling price of $9,430 per unit. Leadless cardiac pacemakers are implantable systems that integrate a battery, pulse generator, sensing and pacing electrodes, communication module, and fixation mechanism into a single or multi-chamber capsule-like device; delivered to the heart via a femoral vein catheter for permanent pacing, they eliminate the need for a subcutaneous chest pocket and transvenous electrode leads. They are primarily used for patients with symptomatic bradycardia, permanent atrial fibrillation with slow ventricular response, sinus node dysfunction, and atrioventricular block, as well as patients with a history of pacemaker pocket infection, those undergoing long-term hemodialysis, those with limited or occluded upper-limb venous access, or those with poor subcutaneous pocket conditions. The upstream supply chain primarily includes medical-grade titanium alloy sealed housings, nitinol fixation structures, platinum-iridium electrodes and conductive coatings, high-energy-density lithium batteries, ASIC chips and microsensors, ceramic/glass insulating feedthroughs, RF communication components, catheter sheaths and polymer materials, and sterilization packaging materials. The midstream sector involves high-precision implantable device manufacturing, encompassing miniaturized packaging, hermetic welding, battery integration, delivery catheter manufacturing, functional testing, sterility validation, clinical trials, and regulatory registrations (such as FDA, CE, and NMPA). The downstream sector primarily consists of large tertiary hospitals, arrhythmia centers, electrophysiology labs, cardiology departments, and post-operative follow-up systems, with hospitals serving as the primary end-users. Gross profit margins range from approximately 50% to 70%.
Regionally, North America benefits from mature payment systems, high coverage of arrhythmia centers, and robust physician training programs, allowing manufacturers like Medtronic and Abbott to lead the way in product adoption and the accumulation of clinical evidence. Growth in Europe is driven by an aging population, a focus on managing infection risks, and increasing acceptance of minimally invasive treatments. While the Asia-Pacific region currently has a relatively low baseline, it is projected to experience rapid growth, with China, Japan, South Korea, India, and Southeast Asia serving as key sources of incremental demand. Looking ahead, the industry is expected to evolve along four main trajectories: shifting from single-chamber to dual-chamber devices; moving from non-retrievable to retrievable and upgradeable systems; expanding from use primarily in high-risk patients to a broader range of indications; and transitioning from inpatient implantation to outpatient and same-day procedures.
This report is a detailed and comprehensive analysis for global Leadless Cardiac Pacemakers market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Leadless Cardiac Pacemakers market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Leadless Cardiac Pacemakers market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Leadless Cardiac Pacemakers market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Leadless Cardiac Pacemakers market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Leadless Cardiac Pacemakers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Leadless Cardiac Pacemakers market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Abbott, Biotronik, Boston Scientific, MicroPort, EBR Systems, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Leadless Cardiac Pacemakers market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single-Chamber Ventricular
Single-Chamber Atrial
Atrioventricular (AV) Synchronous
Dual-Chamber
Market segment by Fixation Mechanism
Flexible Tines/Anchors
Screw-In Mechanism
Market segment by Manageability
Retrievable/Upgradable
Permanent Implant
Market segment by Application
Adults
Children
Major players covered
Medtronic
Abbott
Biotronik
Boston Scientific
MicroPort
EBR Systems
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Leadless Cardiac Pacemakers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Leadless Cardiac Pacemakers, with price, sales quantity, revenue, and global market share of Leadless Cardiac Pacemakers from 2021 to 2026.
Chapter 3, the Leadless Cardiac Pacemakers competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Leadless Cardiac Pacemakers breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Leadless Cardiac Pacemakers market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Leadless Cardiac Pacemakers.
Chapter 14 and 15, to describe Leadless Cardiac Pacemakers sales channel, distributors, customers, research findings and conclusion.